Copyright Reports & Markets. All rights reserved.

Global Anti-Infective Endotracheal Tube Market Insights, Forecast to 2025

Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Anti-Infective Endotracheal Tube Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Anti-Infective Endotracheal Tube Market Size Growth Rate by Product
      • 1.4.2 Silver Coated Endotracheal Tube
      • 1.4.3 Drug Coated Endotracheal Tube
    • 1.5 Market by End User
      • 1.5.1 Global Anti-Infective Endotracheal Tube Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Medical Centers
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Anti-Infective Endotracheal Tube Market Size
      • 2.1.1 Global Anti-Infective Endotracheal Tube Revenue 2014-2025
      • 2.1.2 Global Anti-Infective Endotracheal Tube Sales 2014-2025
    • 2.2 Anti-Infective Endotracheal Tube Growth Rate by Regions
      • 2.2.1 Global Anti-Infective Endotracheal Tube Sales by Regions
      • 2.2.2 Global Anti-Infective Endotracheal Tube Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Anti-Infective Endotracheal Tube Sales by Manufacturers
      • 3.1.1 Anti-Infective Endotracheal Tube Sales by Manufacturers
      • 3.1.2 Anti-Infective Endotracheal Tube Sales Market Share by Manufacturers
      • 3.1.3 Global Anti-Infective Endotracheal Tube Market Concentration Ratio (CR5 and HHI)
    • 3.2 Anti-Infective Endotracheal Tube Revenue by Manufacturers
      • 3.2.1 Anti-Infective Endotracheal Tube Revenue by Manufacturers (2014-2019)
      • 3.2.2 Anti-Infective Endotracheal Tube Revenue Share by Manufacturers (2014-2019)
    • 3.3 Anti-Infective Endotracheal Tube Price by Manufacturers
    • 3.4 Anti-Infective Endotracheal Tube Manufacturing Base Distribution, Product Types
      • 3.4.1 Anti-Infective Endotracheal Tube Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Anti-Infective Endotracheal Tube Product Type
      • 3.4.3 Date of International Manufacturers Enter into Anti-Infective Endotracheal Tube Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Anti-Infective Endotracheal Tube Sales by Product
    • 4.2 Global Anti-Infective Endotracheal Tube Revenue by Product
    • 4.3 Anti-Infective Endotracheal Tube Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Anti-Infective Endotracheal Tube Breakdown Data by End User

    6 North America

    • 6.1 North America Anti-Infective Endotracheal Tube by Countries
      • 6.1.1 North America Anti-Infective Endotracheal Tube Sales by Countries
      • 6.1.2 North America Anti-Infective Endotracheal Tube Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Anti-Infective Endotracheal Tube by Product
    • 6.3 North America Anti-Infective Endotracheal Tube by End User

    7 Europe

    • 7.1 Europe Anti-Infective Endotracheal Tube by Countries
      • 7.1.1 Europe Anti-Infective Endotracheal Tube Sales by Countries
      • 7.1.2 Europe Anti-Infective Endotracheal Tube Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Anti-Infective Endotracheal Tube by Product
    • 7.3 Europe Anti-Infective Endotracheal Tube by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Anti-Infective Endotracheal Tube by Countries
      • 8.1.1 Asia Pacific Anti-Infective Endotracheal Tube Sales by Countries
      • 8.1.2 Asia Pacific Anti-Infective Endotracheal Tube Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Anti-Infective Endotracheal Tube by Product
    • 8.3 Asia Pacific Anti-Infective Endotracheal Tube by End User

    9 Central & South America

    • 9.1 Central & South America Anti-Infective Endotracheal Tube by Countries
      • 9.1.1 Central & South America Anti-Infective Endotracheal Tube Sales by Countries
      • 9.1.2 Central & South America Anti-Infective Endotracheal Tube Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Anti-Infective Endotracheal Tube by Product
    • 9.3 Central & South America Anti-Infective Endotracheal Tube by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Anti-Infective Endotracheal Tube by Countries
      • 10.1.1 Middle East and Africa Anti-Infective Endotracheal Tube Sales by Countries
      • 10.1.2 Middle East and Africa Anti-Infective Endotracheal Tube Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Anti-Infective Endotracheal Tube by Product
    • 10.3 Middle East and Africa Anti-Infective Endotracheal Tube by End User

    11 Company Profiles

    • 11.1 C. R. Bard
      • 11.1.1 C. R. Bard Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 C. R. Bard Anti-Infective Endotracheal Tube Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 C. R. Bard Anti-Infective Endotracheal Tube Products Offered
      • 11.1.5 C. R. Bard Recent Development
    • 11.2 Teleflex
      • 11.2.1 Teleflex Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Teleflex Anti-Infective Endotracheal Tube Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Teleflex Anti-Infective Endotracheal Tube Products Offered
      • 11.2.5 Teleflex Recent Development
    • 11.3 Allvivo Vascular
      • 11.3.1 Allvivo Vascular Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Allvivo Vascular Anti-Infective Endotracheal Tube Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Allvivo Vascular Anti-Infective Endotracheal Tube Products Offered
      • 11.3.5 Allvivo Vascular Recent Development
    • 11.4 Brio Device
      • 11.4.1 Brio Device Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Brio Device Anti-Infective Endotracheal Tube Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Brio Device Anti-Infective Endotracheal Tube Products Offered
      • 11.4.5 Brio Device Recent Development
    • 11.5 Fogless International
      • 11.5.1 Fogless International Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Fogless International Anti-Infective Endotracheal Tube Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Fogless International Anti-Infective Endotracheal Tube Products Offered
      • 11.5.5 Fogless International Recent Development
    • 11.6 Smiths Group
      • 11.6.1 Smiths Group Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Smiths Group Anti-Infective Endotracheal Tube Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Smiths Group Anti-Infective Endotracheal Tube Products Offered
      • 11.6.5 Smiths Group Recent Development
    • 11.7 Becton Dickinson
      • 11.7.1 Becton Dickinson Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Becton Dickinson Anti-Infective Endotracheal Tube Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Becton Dickinson Anti-Infective Endotracheal Tube Products Offered
      • 11.7.5 Becton Dickinson Recent Development
    • 11.8 Ceragenix
      • 11.8.1 Ceragenix Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Ceragenix Anti-Infective Endotracheal Tube Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Ceragenix Anti-Infective Endotracheal Tube Products Offered
      • 11.8.5 Ceragenix Recent Development
    • 11.9 Hollister
      • 11.9.1 Hollister Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Hollister Anti-Infective Endotracheal Tube Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Hollister Anti-Infective Endotracheal Tube Products Offered
      • 11.9.5 Hollister Recent Development
    • 11.10 Medtronic
      • 11.10.1 Medtronic Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Medtronic Anti-Infective Endotracheal Tube Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Medtronic Anti-Infective Endotracheal Tube Products Offered
      • 11.10.5 Medtronic Recent Development

    12 Future Forecast

    • 12.1 Anti-Infective Endotracheal Tube Market Forecast by Regions
      • 12.1.1 Global Anti-Infective Endotracheal Tube Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Anti-Infective Endotracheal Tube Revenue Forecast by Regions 2019-2025
    • 12.2 Anti-Infective Endotracheal Tube Market Forecast by Product
      • 12.2.1 Global Anti-Infective Endotracheal Tube Sales Forecast by Product 2019-2025
      • 12.2.2 Global Anti-Infective Endotracheal Tube Revenue Forecast by Product 2019-2025
    • 12.3 Anti-Infective Endotracheal Tube Market Forecast by End User
    • 12.4 North America Anti-Infective Endotracheal Tube Forecast
    • 12.5 Europe Anti-Infective Endotracheal Tube Forecast
    • 12.6 Asia Pacific Anti-Infective Endotracheal Tube Forecast
    • 12.7 Central & South America Anti-Infective Endotracheal Tube Forecast
    • 12.8 Middle East and Africa Anti-Infective Endotracheal Tube Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Anti-Infective Endotracheal Tube Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      An anti-infective endotracheal tube is a medical device that is used for intubation into the trachea to maintain an open airway and to administer certain drugs
      The anti-infective agents are incorporated in endotracheal polymer coatings of the tube for sustain release, which prevents infection and inflammation of tissues that surround the site of the implant.
      The global Anti-Infective Endotracheal Tube market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Anti-Infective Endotracheal Tube market based on company, product type, end user and key regions.

      This report studies the global market size of Anti-Infective Endotracheal Tube in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anti-Infective Endotracheal Tube in these regions.
      This research report categorizes the global Anti-Infective Endotracheal Tube market by top players/brands, region, type and end user. This report also studies the global Anti-Infective Endotracheal Tube market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      C. R. Bard
      Teleflex
      Allvivo Vascular
      Brio Device
      Fogless International
      Smiths Group
      Becton Dickinson
      Ceragenix
      Hollister
      Medtronic

      Market size by Product
      Silver Coated Endotracheal Tube
      Drug Coated Endotracheal Tube
      Market size by End User
      Hospitals
      Medical Centers

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Anti-Infective Endotracheal Tube market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Anti-Infective Endotracheal Tube market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Anti-Infective Endotracheal Tube companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Anti-Infective Endotracheal Tube submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Anti-Infective Endotracheal Tube are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anti-Infective Endotracheal Tube market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now